Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.

Podobne zapisy

• Fabry's disease: absence of an -galactosidase isozyme.
  od: Wood, S, i wsp.
  Wydane: (1972)
• Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene.
  od: Bernstein, H S, i wsp.
  Wydane: (1989)
• Fabry disease: isolation of a cDNA clone encoding human alpha-galactosidase A.
  od: Calhoun, D H, i wsp.
  Wydane: (1985)
• Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.
  od: Eng, C M, i wsp.
  Wydane: (1993)
• Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease.
  od: Sakuraba, H, i wsp.
  Wydane: (1990)